| Biotechnology feed | All feeds
(Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that four abstracts describing results from... Pharma Live: Nov 10 2008 8:54PM Matching: lymphoproliferative Find similar documents
(NASDAQ: ALTH) today reported results for the third quarter of 2008.
For the three months ended September 30, 2008, the Company reported a net loss of $13.2 million, or ($0.16) per share.
This compares to a net... Genetic Engineering News: Nov 5 2008 10:28PM Matching: lymphoproliferative Find similar documents
(Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that four abstracts describing results from... Pharma Live: Oct 31 2008 12:36PM Matching: lymphoproliferative Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2008 - BioPortfolio Limited.
